Nuwellis (NUWE) EBITDA Margin (2013 - 2026)
Nuwellis (NUWE) posted EBITDA Margin of 190.1% for Q1 2026, down 88.62% on a QoQ basis from 100.78% in Q4 2025, and down 2938.0% year-over-year from 6.7% in Q1 2025.
Nuwellis (NUWE) EBITDA Margin (2013 - 2026) Analysis & Trends
Nuwellis' EBITDA Margin history runs 14 years deep, the most recent figure standing at 190.1% for Q1 2026.
- Quarterly EBITDA Margin fell 2938.0% year-over-year to 190.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 143.85% (down 3802.0% YoY) and the FY2025 annual result came in at 134.29%, down 857.0% from the prior year.
- EBITDA Margin was 190.1% for Q1 2026 at Nuwellis, down from 100.78% in the prior quarter.
- Across five years, EBITDA Margin topped out at 64.72% in Q3 2024 and bottomed at 320.43% in Q1 2023.
- A 5-year average of 171.32% and a median of 168.46% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin sank 9114 bps — and 2024, when it jumped 13628 bps.
- Nuwellis' EBITDA Margin stood at 193.84% in 2022, then increased by 27 bps to 140.85% in 2023, then increased by 27 bps to 102.8% in 2024, then increased by 2 bps to 100.78% in 2025, then slumped by 89 bps to 190.1% in 2026.
- Business Quant data shows NUWE's EBITDA Margin at 190.1% in Q1 2026, 100.78% in Q4 2025, and 121.65% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | -190.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -190.10% |
| Dec 31, 2025 | -100.78% |
| Sep 30, 2025 | -121.65% |
| Jun 30, 2025 | -168.46% |
| Mar 31, 2025 | -160.71% |
| Dec 31, 2024 | -102.80% |
| Sep 30, 2024 | -64.72% |
| Jun 30, 2024 | -105.74% |
| Mar 31, 2024 | -255.74% |
| Dec 31, 2023 | -140.85% |
| Sep 30, 2023 | -131.18% |
| Jun 30, 2023 | -242.02% |
| Mar 31, 2023 | -320.43% |
| Dec 31, 2022 | -193.84% |
| Sep 30, 2022 | -189.83% |
| Jun 30, 2022 | -194.35% |
| Mar 31, 2022 | -229.28% |
| Dec 31, 2021 | -263.76% |
| Sep 30, 2021 | -283.38% |
| Jun 30, 2021 | -188.44% |